Cipher, Ranbaxy Settle Patent Dispute with Actavis over Absorica - (06 Oct 2015)
Cipher Pharma Inc, along with partners Ranbaxy - a Sun Pharma firm - and Galephar Pharmaceutical Research, has entered into a patent litigation settlement with Actavis over generic version of Absorica, a drug used to treat acne.
Tags : CIPHER RANBAXY ABSORICA PATENT
Share :
|